Diederik Dippel received a PhD training in clinical epidemiology and decision sciences and after that, in neurology, at the Erasmus Medical Center in Rotterdam, The Netherlands. He is now a senior consultant in neurology at the Department of Neurology of Erasmus Medical Center.
His main interest is in neurovascular diseases and in acute neurology.
He participates in projects concerning the evaluation of the effect of guidelines on the quality of acute stroke care and secondary prevention after a TIA or stroke, the development and evaluation of clinical tools for prognostic diagnostic decision making in stroke and post-stroke dementia.
He has previously been the principal investigator of PAIS, a Dutch multicenter randomized clinical trial of paracetamol or placebo in acute ischemic stroke, and of PRACTISE, a cluster-randomized trial aimed at resolving barriers to the delivery of thrombolysis in acute ischemic stroke.
Currently, Dr. Dippel is on the Trial Executive Committee for MR CLEAN, a mutli-center randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands.
Charles Majoie is professor and chief of neuroradiology at the Academic Medical Center Amsterdam, the Netherlands. He is an expert in the field of imaging and endovascular treatment of neurovascular diseases.
He is currently chairman of the Dutch Society of Neuroradiology. He has authored more than 190 scientific papers and is involved in multiple national and international research collaborations.
He is co-principal investigator of the MR CLEAN trial, a nationwide randomized controlled trial on endovascular treatment of acute ischemic stroke.
Wim H van Zwam, MD. PhD. is an experienced neurointerventionalist at the Maastricht University Medical Center in The Netherlands. He authored research in the field of imaging in hemorrhagic stroke and intracranial aneurysms, and is currently member of the executive committee of the MRCLEAN trial, a nationwide randomized controlled trial on endovascular treatment of acute ischemic stroke.
Prof.dr. A van der Lugt (M) , is Professor of Neuroradiology and Head/Neck Radiology at Erasmus MC in Rotterdam/NL.
He is Clinical Section Chief Neuroradiology as well as being director of the neuroradiological research program, which encompasses research into neurovascular, neurodegenerative and neuro-oncological diseases.
Prof. van der Lugt’s personal research focuses on 1) vascular imaging (CTA/MRA) with emphasis on the characterization of atherosclerotic disease in the carotid artery with ultrasound, CT, and MRI; 2) evaluation of neurovascular interventions.
Olvert A. Berkhemer finished medical school at Academic Medical Center in Amsterdam. He completed a research fellowship at Massachusetts General Hospital under supervision of Dr. Albert J. Yoo, before the start as a Ph.D. student on the MR CLEAN trial.
Puck S.S. Fransen finished medical school at the Erasmus University in Rotterdam. In 2008 she started her residency in Neurology at the Erasmus Medical Center in Rotterdam. Since 2009 she is involved in the MR CLEAN trial as a Ph.D. student.